ODDB.org: Open Drug Database

Takeda Pharma AG - Edarbi 40mg, Tabletten

Swissmedic Registration	62158	Sequence	02
Product name	Edarbi 40mg	Description	Tabletten
ATC-Classification	C09CA09	ATC-Description	Azilsartan Medoxomil
Introduction of Sequence	31.08.2012

Composition

azilsartanum medoxomilum 40 mg ut azilsartanum medoxomilum kalicum 42.68 mg, mannitolum, acidum fumaricum, natrii hydroxidum, hydroxypropylcellulosum, carmellosum natricum conexum, cellulosum microcristallinum, magnesii stearas, pro compresso, natrium 1.60 mg.

Packungsbestandteile

Galenic Form

Tablets

Active Agent	Dose
Azilsartanum Medoxomilum	40 mg

BAG: Active Agent	Dose
Azilsartanum Medoxomilum	40 mg

Inactive agents	Dose
Acidum Fumaricum
Carmellosum Natricum Conexum
Cellulosum Microcristallinum
Hydroxypropylcellulosum
Magnesii Stearas
Mannitol
Sodium Hydroxide
Sodium	1.6 mg
Pro Compresso

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
004	28 Tablet(s)	21.93	40.25	B	SL	Yes
006	98 Tablet(s)	74.96	97.95	B	SL	Yes
017	14	PR	PR	B		Yes

2025	©ywesee GmbH